In contrast with our findings, the urinary NGAL, but not [TIMP-2] × [IGFBP7], independently predicted AKI in a cohort of decompensated cirrhotic patients, suggesting that different biomarkers should be used in different patient groups [27]. This evidence concerns the gene TIMP2 and acute kidney injury.